# Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients

> **NCT04530877** · PHASE4 · WITHDRAWN · sponsor: **Children's Hospital of Fudan University**

## Conditions studied

- Crohn's Disease
- Exclusive Enteral Nutrition
- Infliximab
- Mucosal Healing

## Interventions

- **BIOLOGICAL:** Infliximab
- **DIETARY_SUPPLEMENT:** Exclusive Enteral Nutrition

## Key facts

- **NCT ID:** NCT04530877
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no funding
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530877, "Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04530877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*